GBT Seeking to Adapt xCalibre Pattern Recognition Technology for Medical Imaging Analytics
Goal of Empowering 2D/3D Intelligent, Post Processing Medical Imaging Analysis
SAN DIEGO, June 08, 2021 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), is seeking to adapt its xCalibre image analysis to post process health related imaging data with the goal of detecting potential issues and providing higher accuracy diagnostics. xCalibre imaging algorithms has the capability of processing high resolution images and videos detecting wide variety of pre-defined irregular objects. Using GBT’s proprietary neural network technology along with its computational geometry algorithms, GBT is seeking to adapt xCalibre to analyze post processed imaging of CT, Ultrasound, MRI and X-RAY. The goal will be to identify abnormalities and alerted medical professionals for further investigation. xCalibre system makes it possible to process and analyze imaging information, identifying anomalies of interest. The system includes technology that is protected with the Company’s recent filed image recognition patent. xCalibre’s cognitive capabilities enables it to learn with time and to accumulate knowledge in the same pattern as a human would.
“we intend to develop our xCalibre system using our proprietary computational geometry algorithms to scan, pixelate and analyze a very high-resolution image. We believe our AI technology could make it a potential intelligent assistant for medical professionals in wide variety of health fields. For example, as an assistance in X-RAYS or Ultrasound images. Another example can be a CT or MRI imaging analysis. Our goal is to implement xCalibre to post process images of MRI, X-RAY, Ultrasound and CT, analyzing for suspicious abnormalities. xCalibre is capable of vast amount of data handling, which enables rapid imaging analytics. We believe that such system can be of a great asset for medical professionals providing what is expected to be a precise image analytics assisting with accurate diagnostics.” Stated Danny Rittman the Company’s CTO.
There is no guarantee that the Company will be successful in researching, developing or implementing this system. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.
About Us
GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.
Forward-Looking Statements
Certain statements contained in this press release may constitute “forward-looking statements”. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.
Contact:
Dr. Danny Rittman, CTO
[email protected]
